Gilead Sciences revela que lenacapavir reduce un 96% las infecciones por VIH en ...
Este es el segundo ensayo de fase 3 que confirma la
superioridad de lenacapavir en la prevención del VIH, lo que podría
abrir la puerta a su ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.